Neutrogena Clear Pore Oil-Eliminating Astringent

Description

Neutrogena® Clear Pore Oil-Eliminating Astringent is a dermatologist-recommended formulation designed for the treatment and prevention of acne. This astringent contains 2% salicylic acid, which effectively addresses breakouts while minimizing the risk of over-drying the skin. The product is enhanced with witch hazel, known for its soothing properties. It is available in an 8 fluid ounce (236 mL) container.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to cleanse the skin thoroughly prior to the application of this product. The affected area should be covered with a thin layer of the formulation one to three times daily, depending on the severity of the condition and the patient's response to treatment.

It is recommended to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's tolerance and clinical response, the frequency of application may be gradually increased to two or three times daily, as needed or as directed by a physician.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day to alleviate these side effects.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame to prevent any risk of ignition.

Skin irritation and dryness may be exacerbated if this product is used concurrently with other topical acne medications. In the event of irritation, it is advised to limit the use to one topical acne medication at a time to minimize adverse effects.

In case of accidental eye contact, it is imperative to flush the eyes thoroughly with water to remove any residual product and reduce the risk of irritation.

This product should be stored out of reach of children. In the event of ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended to ensure appropriate management.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame.

Common adverse reactions include skin irritation and dryness, which are more likely to occur if another topical acne medication is used concurrently. In such cases, it is advised that patients use only one topical acne medication at a time to minimize the risk of irritation.

In the event of eye contact, patients should flush the affected area thoroughly with water to mitigate any potential adverse effects.

Additionally, if the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately. These precautions are essential to ensure the safe use of the product and to address any adverse reactions that may arise.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Clear Pore Oil-Eliminating Astringent (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Clear Pore Oil-Eliminating Astringent in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are specifically applicable to elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in the geriatric population, as individual patient factors may influence safety and efficacy. Monitoring for any adverse effects is advisable when this product is used in elderly patients.

Pregnancy

The safety of salicylic acid during pregnancy has not been established, and its use is contraindicated due to potential risks to the fetus. There may be a risk of teratogenic effects associated with the use of salicylic acid during this period. Pregnant women are advised to consult a healthcare provider before using this product. The use of topical salicylic acid should be avoided during pregnancy unless specifically directed by a healthcare professional.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are monitored closely for any signs of toxicity and that supportive care is initiated as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

It is important to inform patients that the use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if patients experience irritation, they should be instructed to use only one topical acne medication at a time to minimize adverse effects.

Additionally, healthcare providers should counsel patients on the importance of avoiding eye contact with the medication. In case of accidental eye exposure, patients should be directed to flush the eyes thoroughly with water to mitigate any potential irritation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure the product remains within the recommended storage conditions.

Additional Clinical Information

The route of administration for the medication is topical. Clinicians should advise patients to use only one topical acne medication at a time to minimize the risk of irritation. In the event of eye contact, patients should flush the area thoroughly with water. If the medication is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Neutrogena Clear Pore Oil-Eliminating Astringent, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)